Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui-Qin Liu

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Conversion of potent MMP inhibitors into selective TACE inhibitorsRobert J Cherney, Bryan W King, John L Gilmore, et al.
Traffic (Copenhagen, Denmark)|February 9, 2010
Cellular internalization of exosomes occurs through phagocytosisDu Feng, Wen-Long Zhao, Yun-Ying Ye, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Potent P1' biphenylmethyl substituted aggrecanase inhibitorsWenqing Yao, Michael Chao, Zelda R Wasserman, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2007
Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitorsJohn L Gilmore, Bryan W King, Naoyuki Asakawa, et al.
The Journal of Biological Chemistry|January 13, 2004
Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymesMicky D Tortorella, Elizabeth C Arner, Robert Hills, et al.
Investigative Ophthalmology & Visual Science|January 26, 2007
Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIRJoshua M Barnett, Gary W McCollum, Jessica A Fowler, et al.
Molecular Pharmacology|March 27, 2004
Inhibition of tumor necrosis factor-alpha-converting enzyme by a selective antagonist protects brain from focal ischemic injury in ratsXinkang Wang, Giora Z Feuerstein, Lin Xu, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2008
Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituentsZhonghui Lu, Gregory R Ott, Rajan Anand, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2006
Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)James J-W Duan, Lihua Chen, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2006
Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)James E Sheppeck, John L Gilmore, Anle Yang, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Conversion of potent MMP inhibitors into selective TACE inhibitorsRobert J Cherney, Bryan W King, John L Gilmore, et al.
Traffic (Copenhagen, Denmark)|February 9, 2010
Cellular internalization of exosomes occurs through phagocytosisDu Feng, Wen-Long Zhao, Yun-Ying Ye, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Potent P1' biphenylmethyl substituted aggrecanase inhibitorsWenqing Yao, Michael Chao, Zelda R Wasserman, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2007
Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-alpha converting enzyme inhibitorsJohn L Gilmore, Bryan W King, Naoyuki Asakawa, et al.
The Journal of Biological Chemistry|January 13, 2004
Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymesMicky D Tortorella, Elizabeth C Arner, Robert Hills, et al.
Investigative Ophthalmology & Visual Science|January 26, 2007
Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIRJoshua M Barnett, Gary W McCollum, Jessica A Fowler, et al.
Molecular Pharmacology|March 27, 2004
Inhibition of tumor necrosis factor-alpha-converting enzyme by a selective antagonist protects brain from focal ischemic injury in ratsXinkang Wang, Giora Z Feuerstein, Lin Xu, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2008
Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituentsZhonghui Lu, Gregory R Ott, Rajan Anand, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2006
Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)James J-W Duan, Lihua Chen, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2006
Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)James E Sheppeck, John L Gilmore, Anle Yang, et al.
Pageof 4